TickerFactsScreenerDevelopers

Actinium Pharmaceuticals, Inc. (ATNM) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2012: $2.4K2013: $16.6K2014: $151.7K2015: $47.8K2016: $60.0K2017: $24.7K2018: $96.1K2019: $64.0K2020: $253.0K2021: $133.0K2022: $366.0K2023: $153.0K2024: $11.0K2025: $104.0K$104.0K
2012Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$104.0K+845.5%
2024$11.0K-92.8%
2023$153.0K-58.2%
2022$366.0K+175.2%
2021$133.0K-47.4%
2020$253.0K+295.3%
2019$64.0K-33.4%
2018$96.1K+288.4%
2017$24.7K-58.7%
2016$60.0K+25.5%
2015$47.8K-68.5%
2014$151.7K+814.2%
2013$16.6K+603.3%
2012$2.4K—